BECTON DICKINSON & CO — Director's Dealing 2020

Jul 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2020-07-09

Reporting Person: Kaltenbach Patrick (EVP & Pres Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-09	Common Stock	S	1272	$260.00	Disposed	10340	Direct

Footnotes

F1: This transaction was made pursuant to a 10b5-1 plan entered into on December 13, 2019.